A multi-centre study of sulindac versus naproxen in the treatment of elderly osteoarthritic patients

A multi-centre study of sulindac versus naproxen in the treatment of elderly osteoarthritic patients

Ninety-five geriatric patients with osteoarthritis of the hip and/or knee were entered into an open parallel group study of sulindac (400 mg/day) and naproxen (500 mg/day), both given in twice-daily regimens. Patients received the drugs for 12 weeks. Both drugs produced improvements in the patients&...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC). - 1995. - 3(1984), 10 vom: 20., Seite 663-7
1. Verfasser: Janke, P G (VerfasserIn)
Weitere Verfasser: Diggins, J B, Currie, W J, Dasgupta, P K, Glick, E N, Sheikh, N A, Shujja-Ud-Din
Format: Aufsatz
Sprache:English
Veröffentlicht: 1984
Zugriff auf das übergeordnete Werk:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)
Schlagworte:Clinical Trial Comparative Study Journal Article Randomized Controlled Trial Indenes Sulindac 184SNS8VUH Naproxen 57Y76R9ATQ